G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01) C12Q 1/26 (2006.01) C12Q 1/60 (2006.01)
Patent
CA 2349229
The present invention provides a method of assaying for and arresting, preventing and/or reversing the impairment of central and peripheral nervous system function comprising reducing .beta.-amyloid plaque burden by the administration of compounds that reduce apoE expression. The compounds used in the method of the invention may be: 1) inhibitors of 3-hydroxy-3- methylglutaryl coenzyme A (HMG CoA) reductase; 2) inhibitors of cholesterol biosynthesis; 3) inhibitors of protein isoprenylation, specifically geranylgeranylation; and/or 4) inhibitors of NF-~B activation or function. Assays for compounds with inhibit apoE expression from microglial cells are also disclosed.
L'invention concerne une méthode d'analyse permettant de stopper, de prévenir et/ou d'inverser la dégénérescence des fonctions des systèmes nerveux central et périphérique. Cette méthode consiste à réduire la plaque .beta.-amyloïde par l'administration de composés qui réduisent l'expression d'apoE. Les composés utilisés dans la méthode selon l'invention peuvent être: 1) des inhibiteurs de 3-hydroxy-3-méthylglutaryle coenzyme A (HMG CoA) réductase; 2) des inhibiteurs de la biosynthèse du cholestérol; 3) des inhibiteurs d'isoprénylation de protéines, notamment de géranylgéranylation de protéines; et/ou 4) des inhibiteurs de l'activation ou de la fonction de NF-~B. L'invention concerne également des analyses permettant d'obtenir des composés inhibant l'expression d'apoE dans les microglies.
Bales Kelly Renee
Cordell Barbara
Naidu Asha
Paul Steven Marc
Xu Qiang
Eli Lilly & Company
Fetherstonhaugh & Co.
Scios Inc.
LandOfFree
Prevention and treatment of amyloid-associated disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention and treatment of amyloid-associated disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of amyloid-associated disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1673346